Linuo Showcases High-End Pharmaceutical Glass Packaging at Pharmtech & Ingredients 2025
Continuous Market Engagement and One-Stop Solutions
From November 25 to 28, Pharmtech & Ingredients 2025 concluded successfully at the Crocus Expo International Exhibition Center in Moscow. Linuo Pharmaceutical Packaging’s President, Mr. Sun Pengfei, along with our overseas marketing team, attended the exhibition, demonstrating our unwavering commitment to deepening engagement in the CIS (Commonwealth of Independent States) market.
Connecting Global Partners, Strengthening Regional Presence
Russia, as a key strategic partner of the Belt and Road Initiative, represents immense potential in the CIS market. With the ongoing development of trade relations between China and Russia, the business volume in this region is steadily growing. Pharmtech & Ingredients 2025, one of the premier exhibitions in the pharmaceutical raw materials and technology sector in Russia and the Eurasian Economic Union, attracted over 10,000 professional visitors from more than 27 countries and regions, with more than 560 exhibiting companies. It served as a pivotal platform connecting the Eurasian pharmaceutical industry and driving regional innovation.
Linuo Pharmaceutical Packaging actively leveraged this international platform to engage with customers across CIS countries, discussing product variety, localized services, and supply chain support. We provided tailored solutions based on market policies and individual client requirements, showcasing our robust capabilities and diversified service offerings in pharmaceutical glass packaging, sterile primary packaging, prefilled syringes (PFS), and ready-to-use (RTU) delivery systems.
Showcasing Core Strengths and Long-Term Development Strategy
At the exhibition, President Sun Pengfei engaged with the event’s media and interview teams, highlighting Linuo’s continued global expansion and strategic insight into high-end, green, and intelligent development trends in the pharmaceutical packaging industry. Our key initiatives include:
Expanding the Product Matrix: Increased R&D investment to strengthen our primary packaging portfolio and advance into PFS & RTU delivery devices and high-end sterile packaging. All products meet EP, USP, JP, and Chinese Pharmacopoeia standards, with FDA DMF and Health Canada MF registration numbers, ensuring comprehensive, efficient one-stop solutions for pharmaceutical packaging.
Intelligent Manufacturing: Implementation of smart production equipment and digital management systems to establish a “Lighthouse Factory,” delivering higher quality, efficiency, and scale advantages to support global clients.
Localized Services: Building an international support and technical service network to enhance response efficiency and upgrade our cooperation from “product supply” to “deep collaboration,” maximizing client value.
Recognition and Future Outlook
Linuo Pharmaceutical Packaging received significant recognition and numerous collaboration intentions at Pharmtech & Ingredients 2025, marking another milestone in our international strategy. With over 30 years of industry experience and technological expertise, we will continue to deepen our global market presence. Through efficient one-stop solutions in pharmaceutical glass packaging, PFS & RTU devices, and sterile primary packaging, Linuo is committed to partnering with global stakeholders to contribute to human health and the advancement of the pharmaceutical industry.
Follow us on Instagram for the latest updates on Linuo’s innovative pharmaceutical packaging solutions. Learn more about our Prefilled Syringes (PFS) and Ready-to-Use (RTU) delivery systems, and discover how we provide efficient, one-stop packaging solutions for global clients.
